Bank of America
PLYX

Bank of America’s Polaryx Therapeutics Inc PLYX Stock Holding History

Bank of America’s Portfolio PLYX Stock Details PLYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$196K Buy
+25,881
New +$167K ﹤0.01% 5368

Other funds holding PLYX

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

Bank of America's PLYX Position: Q1 2026 in Review

Bank of America opened a new position in Polaryx Therapeutics Inc (PLYX) in Q1 2026: 25,881 shares worth $196K. The stake represents ﹤0.01% of the portfolio and ranks #5368 among its holdings.

14 funds tracked by Wall St. Rank hold PLYX as of Q1 2026.

  • Bank of America held 25,881 shares of Polaryx Therapeutics Inc worth $196K as of Q1 2026.
  • Polaryx Therapeutics Inc was a new Bank of America position in Q1 2026.
  • Polaryx Therapeutics Inc made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #5368 holding.
  • 14 funds tracked by Wall St. Rank held Polaryx Therapeutics Inc as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.